Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
AACR Annual Meeting
AACR Issues New Policy on Tobacco Use
By
Phoebe Starr
AACR Annual Meeting
May 2013, Vol 4, No 4
Washington, DC—Tobacco use among patients with cancer is an important but often overlooked issue that requires intervention by oncology practices. In recognition of the problem and the gap between the need for intervention and the services delivered, the American Association for Cancer Research (AACR) issued a policy on tobacco use at its 2013 annual meeting.
Read Article
Ibrutinib Shows Rapid, Dramatic Responses in Patients with CLL
By
Charles Bankhead
AACR Annual Meeting
May 2013, Vol 4, No 4
Washington, DC—More than 50% of patients with difficult-to-treat chronic lymphocytic leukemia (CLL) had tumor shrinkage during 6 months of treatment with ibrutinib, results of a phase 2 clinical trial showed.
Read Article
Late-Breaking Clinical Trials: Potential New Therapies for Lymphoma, Prostate, and Other Cancers
AACR Annual Meeting
June 2012, Vol 3, No 4
Chicago, IL—Several presentations featured at a news conference at the 2012 American Association for Cancer Research meeting highlighted new therapies showing promising results in the early stage of research, potentially charting new options for patients with cancer.
Read Article
Brain, Breast, and Liver Cancers All Respond to Immunotherapy
By
Richard Hyer
AACR Annual Meeting
June 2012, Vol 3, No 4
There is progress in at least 4 areas: pediatric brain tumors, breast cancer, hepatocellular carcinoma, and generally advanced cancers, according to 4 current studies described at the 2012 American Association for Cancer Research meeting.
Read Article
Can Whole-Genome Sequencing Predict Future Cancer?
AACR Annual Meeting
May 2012, Vol 3, No 3
Chicago, IL—For the individual at average risk for disease, whole-genome sequencing (WGS)—mapping the sequence of one’s full set of genetic material—is not a crystal ball to reliably predict future health, according to a study presented at the 2012 American Association for Cancer Research meeting.
Read Article
Metformin Protects Against Several Cancers
By
Richard Hyer
AACR Annual Meeting
May 2012, Vol 3, No 3
Chicago, IL—Metformin cannot seem to stay out of the news. This antidiabetes drug that is derived from the French lilac is now also thought to possibly protect against liver cancer, lower the risk for oral cancer, improve prognosis of pancreatic cancer in diabetic patients, and increase response to melanoma tumors with BRAF mutations when used in combination with a common cancer drug, according to several studies presented at the 2012 American Association for Cancer Research meeting.
Read Article
Advances in Personalized Medicine: Focus on Prostate and Brain Cancers
By
Richard Hyer
AACR Annual Meeting
May 2012, Vol 3, No 3
Chicago, IL—Targeting prostate cancer with extreme accuracy, using tissue oxygen content to predict its recurrence, and using breast cancer drugs on brain tumors were a few highlights of a news conference on advances in personalized medicine at the 2012 American Association for Cancer Research meeting.
Read Article
Significant Advances in Lung Cancer Highlighted at AACR
By
Caroline Helwick
AACR Annual Meeting
June 2011, Vol 2, No 3
Orlando, FL—Lung cancer studies made news at the 2011 American Association of Cancer Research annual meeting.
Read Article
$3 Million to Toss a Life Ring?
AACR Annual Meeting
June 2010, Vol 1, No 2
Washington, DC—Three million dollars to toss a life ring? That’s what the pharmaceutical industry would charge, the director of Medical Ethics at Harvard’s School of Medicine suggested at the 101st Annual Meeting of the American Association for Cancer Research (AACR), held April 17-21 in Washington, DC.
Read Article
Linked Databases, Health IT, and Informatics Essential for CER and Personalized Medicine
AACR Annual Meeting
,
Comparative Effectiveness Research
June 2010, Vol 1, No 2
Washington, DC—Health information technology (IT) and informatics are fundamental to all comparative effectiveness research (CER), Amy Abernethy, MD, associate director of the Duke Comprehensive Medical Center and founder and director of the Duke Cancer Care Research Program, told attendees at a session of the American Association of Cancer Research (AACR) 101st Annual Meeting.
Read Article
Page 2 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma